Optho Pharma

Prayagraj, India
Manufacturing of ophthalmic products and eye care solutions in India.

About Optho Pharma

Optho Pharma is a company based in Prayagraj (India). The company has 22 employees. Optho Pharma offers products and services including Lubricating Eye Drops and Ophthalmic Ointments.

  • Headquarter Prayagraj, India
  • Employees 22
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Legal Name Optho Pharma Pvt. Ltd
  • Date of Incorporation 15 Oct, 2018
  • Jurisdiction Allahabad, Uttar Pradesh, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹7.37 Cr

    FY 2024 · -9% YoY

  • Net Profit
    ₹33.9 Lakh

    FY 2024 · 5% margin

  • EBITDA
    ₹50.9 Lakh

    FY 2024 · 7% margin

  • Employee Count
    22

Products & Services of Optho Pharma

Optho Pharma offers a comprehensive portfolio of products and services, including Lubricating Eye Drops and Ophthalmic Ointments.

Lubricating Eye Drops
Ophthalmic Products

These eye drops are utilized for advanced dry eye relief and are formulated to be preservative-free.

Ophthalmic Ointments
Eye Care Formulations

Ointments are employed as advanced, sterile formulations for various eye care needs.

Board of directors of Optho Pharma Private Limited (Optho Pharma)

Optho Pharma Private Limited is the primary company behind Optho Pharma. The board of Optho Pharma Private Limited currently have 2 directors; the longest-serving is Rohit Agarwal, appointed in 2018.

DirectorDesignationAppointedTenureEntity
Rohit Agarwal
DIN 08257242
Director15 Oct 20187 yrs 11 moOptho Pharma Private Limited
Rajesh Agarwal
DIN 00245357
Director15 Oct 20187 yrs 11 moOptho Pharma Private Limited

Financials of Optho Pharma

Figures of Optho Pharma Private Limited, the primary company behind Optho Pharma, for FY 2024. Revenue was ₹7.37 Cr (-9% year on year). Net profit was ₹33.9 Lakh (5% margin). EBITDA was ₹50.9 Lakh (7% margin). Revenue has grown at a compounded annual rate of -3% over three years and +7% over five years.

  • ₹7.37 CrRevenue · FY 2024 · -9% YoY
  • ₹33.9 LakhNet profit · 5% margin
  • ₹50.9 LakhEBITDA · 7% margin
  • ₹41.4 LakhPaid-up capital
  • 22Employees (provident fund records)
  • -3%Revenue CAGR, 3 years
  • +7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Optho Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Optho Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Optho Pharma

10 companies that operate in the same segment as Optho Pharma (Ophthalmology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 9.64 B25,600
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M–100
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
2003Alpharetta, Georgia, United StatesUSD 66.8 MUSD 80.75 M79
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
2009Bengaluru, Karnataka, IndiaUSD 25.01 MUSD 4.85 M135
Gene therapies for ocular and neurodegenerative diseases are developed.
2015New York, New York, United States–USD 81.39 M381
Small molecule therapeutics for ophthalmic disorders are developed.
1987Watertown, United States–USD 31.37 M165
Therapies for metabolic and orphan diseases are developed by Rezolute.
2012Denver, Colorado, United States––59
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
2010Bengaluru, Karnataka, IndiaUSD 18.12 MUSD 4.78 M145
Therapeutics for retinal diseases are developed by the company.
2009Palo Alto, California, United StatesUSD 35.84 M–109
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Optho Pharma

Optho Pharma is headquartered in Prayagraj, India. It is registered at Prayagraj, Uttar Pradesh, India.

Optho Pharma has 22 employees.

The primary company behind Optho Pharma, Optho Pharma Private Limited, reported revenue of β‚Ή7.37 Cr for FY 2024, down 9% year on year.

Optho Pharma has been recognized for its involvement in manufacturing specialized eye care products, ranging from general to specific therapeutic needs, for over 55 years. Products are distributed across India and beyond, with a strong emphasis placed on both prevention and cure in eye care. Research and innovation are conducted through state-of-the-art facilities, ensuring rigorous quality control and clinical trials. Diversification into other healthcare segments has been achieved, maintaining a commitment to superior, tailored formulations.

Optho Pharma offers Lubricating Eye Drops and Ophthalmic Ointments.

Optho Pharma operates through Optho Pharma Private Limited.

The legal entities of Optho Pharma currently have 2 directors, including Rohit Agarwal, Rajesh Agarwal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available